#trumprx

#trumprx

President Donald Trump is launching a new government-run website that he says will let Americans buy medications at lower prices. The new website, called TrumpRx, is expected to launch in 2026 and will direct consumers to discounts on drugmakers' online stores, including Pfizer's, as reported earlier by The New York Times and . The Tuesday announcement comes as part of a deal that grants Pfizer a three-year reprieve from tariffs in exchange for investing in US-based manufacturing, according to the company's press release.

Pfizer (NYSE:PFE) shares are finally starting to attract attention after gaining close to 7% in a single trading session on news that it's reached a pricing deal with the Trump administration. Indeed, this is the biggest up day for shares of PFE in recent memory. And while investors are upbeat on the pricing plan, I do think that income investors should focus on the longer-term opportunity at hand.